Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Treasury Shares: 2023-2024

Historic Treasury Shares for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $3.8 million.

  • Compass Therapeutics' Treasury Shares fell 65.14% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 65.14%. This contributed to the annual value of $3.8 million for FY2024, which is 151.07% up from last year.
  • As of FY2024, Compass Therapeutics' Treasury Shares stood at $3.8 million, which was up 151.07% from $1.5 million recorded in FY2023.
  • Over the past 5 years, Compass Therapeutics' Treasury Shares peaked at $3.8 million during FY2024, and registered a low of $1.5 million during FY2023.
  • Its 2-year average for Treasury Shares is $2.6 million, with a median of $2.6 million in 2023.
  • Data for Compass Therapeutics' Treasury Shares shows a peak YoY soared of 151.07% (in 2024) over the last 5 years.
  • Compass Therapeutics' Treasury Shares (Yearly) stood at $1.5 million in 2023, then surged by 151.07% to $3.8 million in 2024.